Maypharm unveils HYALMASS AQUATOX, a next‑generation multi‑active skincare aimed at the global aesthetic medicine market
Executive summary: Maypharm announced the upcoming launch of HYALMASS AQUATOX, a multi‑active skincare formulation for the global aesthetic medicine market. The launch expands Maypharm’s product line in a high‑growth cosmetic segment and signals intensified competition in the global aesthetic medicine market.
Who is involved: Maypharm (South Korea‑based aesthetics and cosmeceutics company) and its product development team.
Likely next: The company will proceed with product rollout and marketing efforts ahead of the anticipated launch date.
Maypharm, a South Korea‑based aesthetics and cosmeceutics company, disclosed that it will soon introduce HYALMASS AQUATOX, a multi‑active skincare formulation aimed at the global aesthetic medicine market. The press release characterizes the product as a next‑generation solution designed to meet evolving consumer preferences for advanced, multi‑functional skin‑care products. No information about the exact launch date, pricing, or projected sales figures was provided in the announcement. The move reflects Maypharm’s strategy to broaden its portfolio beyond existing offerings and to tap into the sustained demand for scientifically backed aesthetic treatments. By presenting a formulation that combines several active ingredients, the company seeks to differentiate itself in a competitive space where clinicians and consumers increasingly look for products that deliver multiple benefits in a single application. While the announcement does not detail regulatory steps, the product will likely need to satisfy the relevant safety and efficacy standards in each target market before it can be made available to physicians and consumers. In the near term, observers can expect Maypharm to proceed with the necessary approvals and to begin building the distribution channels required for a worldwide rollout.
Timeline
- — MAYPHARM stellt HYALMASS AQUATOX vor, eine multiaktive Hautpflege der nächsten Generation für den globalen Markt für ästhetische Medizin (PR Newswire)
- — MAYPHARM dévoile HYALMASS AQUATOX, une solution multi-active de nouvelle génération pour la peau, destinée au marché mondial de l'esthétique (PR Newswire)
- — MAYPHARM presenta HYALMASS AQUATOX, una solución multiactiva de nueva generación para la piel (PR Newswire)
Key entities
Sources
- MAYPHARM stellt HYALMASS AQUATOX vor, eine multiaktive Hautpflege der nächsten Generation für den globalen Markt für ästhetische Medizin — PR Newswire
- MAYPHARM dévoile HYALMASS AQUATOX, une solution multi-active de nouvelle génération pour la peau, destinée au marché mondial de l'esthétique — PR Newswire
- MAYPHARM presenta HYALMASS AQUATOX, una solución multiactiva de nueva generación para la piel — PR Newswire
Related cases
- CARKU unveils sodium‑ion jump starter and batteries at Automechanika Frankfurt 2026, signaling a move toward lithium‑alternatives in automotive starting systems
- Nocpix expands flagship thermal imaging portfolio with the launch of the ACE 2 series
- MSA Safety launches the A1X WinGrip vacuum anchor, aiming to make aircraft maintenance safer, faster and more versatile
- SATELLAI advances AI-driven pet wellbeing technology with new wearables at IFA 2026
- CARKU’s European rollout of next‑generation sodium‑ion jump starters aligns with the looming EU ECGT Directive, positioning the firm to capture early‑mover advantage in the automotive aftermarket
- LumenStim readies a peroxide‑free, Kickstarter‑launched next‑generation teeth whitening system while pursuing global patents